Fereidoun Abtin, MD

Dr. Fereidoun Abtin is a thoracic interventional radiologist at the UCLA Medical Center in Santa Monica, California. He specializes in interventions for cancers of the chest and has earned international respect as an expert in the minimally invasive treatment of lung cancer, malignant pleural mesothelioma, and thymoma. Dr. Abtin is skilled in lung biopsy and

Tirrell Tremayne Johnson, MD

Dr. Tirrell Tremayne Johnson is a medical oncologist and member of the Hematology and Thoracic/Head and Neck Cancers Specialty sections at Orlando Health Cancer Institute in Orlando, Florida. He specializes in treating patients diagnosed with thoracic cancers, including lung cancer, malignant pleural mesothelioma, and thymoma, as well as cancers affecting the head and neck. Dr.

Anne-Marie G. Sykes, MD

Dr. Anne-Marie G. Sykes is a radiologist specializing in imaging of the chest at the Mayo Clinic in Rochester, Minnesota. She has years of experience in diagnosing and imaging diseases of the chest, working collaboratively with a multidisciplinary team of physicians from other areas of medicine to create treatment plans for patients diagnosed with lung

Jun Zhang, MD, PhD

Dr. Jun Zhang is a medical oncologist, physician, and scientist at KU Medical Center of the University of Kansas in Kansas City. He is passionate about both patient care and research, working to carry scientific discoveries to the bedsides of patients diagnosed with lung cancer, malignant pleural mesothelioma, and other thoracic malignancies. Dr. Zhang serves

Linda Garland, MD

Dr. Linda Garland is a thoracic medical oncologist at the University of Arizona Banner Health. She has expertise in lung cancer and malignant pleural mesothelioma and is particularly interested in the use of experimental therapeutics to improve patient outcomes. Education and Career Dr. Garland earned her medical degree at the University of Texas Health Science Center.

Helen J. Ross, MD

Dr. Helen J. Ross is a medical oncologist who specializes in the treatment of lung cancers of all types, including malignant pleural mesothelioma, at RUSH University Cancer Center in Chicago, Illinois. In addition to her role as professor of Internal Medicine, Oncology and as Interim Chief of the Division of Hematology, Oncology, and Cellular Therapy,

Evan Osmundson, MD, PhD

Dr. Evan Osmundson is a radiation oncologist specializing in lung cancer, mesothelioma, and thoracic cancers at Vanderbilt University Medical Center in Nashville, Tennessee. He is highly skilled in the use of innovative radiation treatments, including, 3D conformal radiation, adaptive radiotherapy, Intensity-Modulated Radiation Therapy (IMRT), Stereotactic Body Radiotherapy, Stereotactic Radiosurgery, Total Body Radiation, and Total Skin

Andreas Saltos, MD

Dr. Andreas Saltos is a board-certified medical oncologist at the Moffitt Cancer Center in Tampa, Florida. He specializes in treating patients with thoracic malignancies, including those diagnosed with malignant pleural mesothelioma and all types of lung cancer, at all stages. His treatment approach is centered on identifying the most appropriate treatment protocol to meet his

Jeffrey P. Ward, MD, PhD

Dr. Jeffrey P. Ward is a physician-scientist at the Siteman Cancer Center and Washington University School of Medicine with a particular interest in thoracic oncology. His patient care is focused on treating patients diagnosed with lung cancer and other thoracic malignancies. He works to leverage innovations, including immunotherapy treatments, to develop better strategies that arm

Mark A. Socinski, MD

Dr. Mark A. Socinski is a medical oncologist and Executive Director of the AdventHealth Cancer Institute in Orlando, Florida. He specializes in thoracic malignancies including pleural mesothelioma and non-small and small cell lung cancers and is an internationally recognized expert in the development of novel chemotherapy agents and treatment strategies for those diseases. Education and

Get Help Contacting Mesothelioma.net
This field is for validation purposes and should be left unchanged.
24/7 Live Chat
Online Now